Luminex logo

LMNX - Luminex News Story

$32.95 0.7  2.1%

Last Trade - 09/04/21

Sector
Healthcare
Size
Mid Cap
Market Cap £1.14bn
Enterprise Value £1.06bn
Revenue £304.5m
Position in Universe 2442nd / 6827

BUZZ-Luminex Corp: Rises after BARDA funding for COVID-19 test development

Tue 31st March, 2020 2:17pm
** Shares of medical test maker  LMNX.O  rise 4.8% to $27.70
premarket
    ** LMNX receives $642,450 from the Biomedical Advanced
Research and Development Authority (BARDA) to fund development,
testing and submission for an Emergency Use Authorization (EUA)
for its COVID-19 detection test  urn:newsml:reuters.com:*:nPn1DrHzPa
    ** The test, ARIES SARS-CoV-2 Assay, is designed to generate
results in approximately two hours
    **  Luminex intends to price the test below current
government reimbursement levels
    ** BARDA is part of U.S. Department of Health and Human
Services and is tasked with protecting the country against
emerging infectious diseases and other threats
    ** Last week, Luminex received a BARDA contract and an FDA
EUA for another coronavirus test that provides results for up to
96 samples in approximately four hours
    ** Up to Monday's close, LMNX rose ~14% YTD

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.